X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Reflecting on terrific progress in treating diabetes

By Bill Chin, M.D.  |    November 17, 2016
There is no doubt that diabetes is a complex disease to diagnose and treat. That’s something I’ve seen firsthand as an endocrinologist. Over the years, I treated a number of patients that had a...   Read More

Continuing the search for new Alzheimer’s therapies

By Nicole Longo  |    November 10, 2016
Designated in 1983 by then-President Ronald Reagan, November marks National Alzheimer’s Disease Awareness Month – a month for all Americans to come together to raise awareness and understanding of...   Read More

Eradication of measles highlights the promise of vaccines in development

By Hannah Mooney  |    September 29, 2016
On September 27, the Pan American Health Organization (PAHO) alongside the World Health Organization (WHO) announced that the Region of the Americas is the first region in the world to have...   Read More

Celebrating hope for patients and families on World Heart Day 2016

By Hannah Mooney  |    September 29, 2016
My heart lives in Portland, Ore. The reason I do my work is there too. That’s where I grew up and where I saw my grandfather earlier this month. If you ask him how he is doing, he’ll say, “I’m...   Read More

New report highlights more than 250 vaccines in development

By Hannah Mooney  |    August 18, 2016
More than 200 years ago, the first vaccine was developed for smallpox, and now, the disease has been eradicated worldwide. And in the United States, the transmission of poliovirus, measles and...   Read More

Using setbacks as stepping stones in Alzheimer’s research

By Gretta Stone  |    August 3, 2016
For decades, biopharmaceutical researchers have worked tirelessly in the pursuit of new treatments and cures for the costly and devastating Alzheimer’s disease. Advancing treatments for...   Read More

New report: Decade of breakthroughs in cancer

By Emma Van Hook  |    June 2, 2016
The pace of science is yielding remarkable innovation for cancer patients as we learn more about the underlying factors driving the spread and growth of cancer. These advances are opening new...   Read More

Cost of mental illness underscores need for new treatments

By Holly Campbell  |    May 25, 2016
Today, one in five American adults and children experience a mental illness in any given year. As the prevalence of complex mental health conditions has grown, the cost of caring for patients has...   Read More

New PhRMA Report: Medicines in development for patients with rare diseases demonstrate the promise of innovation

By Ieva M. Augstums  |    May 9, 2016
Today, there are 7,000 known rare diseases, or diseases that affect fewer than 200,000 people in the United States. But those suffering from the impact of these diseases have more hope today...   Read More

Medicare Monday: Advancing treatments for osteoporosis with medicines in development

By Nicole Longo  |    March 28, 2016
Since the implementation of Medicare Part D, we’ve seen numerous signs of success when it comes to how the program works and how it helps seniors and individuals with disabilities live longer,...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates